Say Goodbye to Methotrexate in PMR? Despite mixed results on its clinical efficacy in three previous randomised contro
Tweet Content
Say Goodbye to Methotrexate in PMR?
Despite mixed results on its clinical efficacy in three previous randomised controlled trials (RCTs)1-3, methotrexate is considered the most widely used GC sparing agent. #ACR24
https://t.co/Q5Sw9dvYqJ https://t.co/jvEmg6aPcq
Links
Say Goodbye to Methotrexate in PMR? | RheumNow
https://buff.ly/4eDnkNw
Show on Archive Page
On
Display in Search Results
On
PDQ
Off